Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000596195 | SCV000702456 | uncertain significance | not provided | 2016-11-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084102 | SCV001020771 | benign | Kleefstra syndrome 1 | 2025-01-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000596195 | SCV001941047 | benign | not provided | 2020-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456297 | SCV002737604 | benign | Inborn genetic diseases | 2019-09-30 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003905517 | SCV004718285 | likely benign | EHMT1-related disorder | 2022-04-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |